You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

DICYCLOMINE HYDROCHLORIDE Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Dicyclomine Hydrochloride, and when can generic versions of Dicyclomine Hydrochloride launch?

Dicyclomine Hydrochloride is a drug marketed by Annora Pharma, Aurobindo Pharma Usa, Corepharma, Lannett, Pioneer Pharms, Prinston Inc, Sun Pharm Industries, Twi Pharms, Watson Labs, West Ward, Am Regent, Dr Reddys, Fosun Pharma, Fresenius Kabi Usa, Hikma, Nexus, Praxgen Pharms, Renew Pharms, Slate Run Pharma, Alpharma Us Pharms, Endo Operations, Novitium Pharma, Bionpharma, Hikma Pharms, and Rubicon. and is included in thirty-seven NDAs.

The generic ingredient in DICYCLOMINE HYDROCHLORIDE is dicyclomine hydrochloride. There are four drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the dicyclomine hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Dicyclomine Hydrochloride

A generic version of DICYCLOMINE HYDROCHLORIDE was approved as dicyclomine hydrochloride by WATSON LABS on June 19^th, 1986.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for DICYCLOMINE HYDROCHLORIDE?
What are the global sales for DICYCLOMINE HYDROCHLORIDE?
What is Average Wholesale Price for DICYCLOMINE HYDROCHLORIDE?

Summary for DICYCLOMINE HYDROCHLORIDE

US Patents:	0
Applicants:	25
NDAs:	37
Finished Product Suppliers / Packagers:	53
Raw Ingredient (Bulk) Api Vendors:	63
Patent Applications:	997
DailyMed Link:	DICYCLOMINE HYDROCHLORIDE at DailyMed

Drug patent expirations by year for DICYCLOMINE HYDROCHLORIDE

Pharmacology for DICYCLOMINE HYDROCHLORIDE

Drug Class	Anticholinergic
Mechanism of Action	Cholinergic Antagonists

Medical Subject Heading (MeSH) Categories for DICYCLOMINE HYDROCHLORIDE

Muscarinic Antagonists
Parasympatholytics

US Patents and Regulatory Information for DICYCLOMINE HYDROCHLORIDE

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Rubicon	DICYCLOMINE HYDROCHLORIDE	dicyclomine hydrochloride	TABLET;ORAL	216736-001	Dec 14, 2022	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Corepharma	DICYCLOMINE HYDROCHLORIDE	dicyclomine hydrochloride	TABLET;ORAL	216760-001	Nov 28, 2022	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Sun Pharm Industries	DICYCLOMINE HYDROCHLORIDE	dicyclomine hydrochloride	TABLET;ORAL	084600-001	Jul 29, 1985		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Hikma Pharms	DICYCLOMINE HYDROCHLORIDE	dicyclomine hydrochloride	TABLET;ORAL	040161-001	Oct 1, 1996	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Annora Pharma	DICYCLOMINE HYDROCHLORIDE	dicyclomine hydrochloride	CAPSULE;ORAL	218018-001	Jul 1, 2024	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Praxgen Pharms	DICYCLOMINE HYDROCHLORIDE	dicyclomine hydrochloride	INJECTABLE;INJECTION	212058-001	Apr 26, 2019		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Novitium Pharma	DICYCLOMINE HYDROCHLORIDE	dicyclomine hydrochloride	SYRUP;ORAL	214721-001	Apr 23, 2021	AA	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.